Company profile for Extrovis AG

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and custom...
Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and customer service. Extrovis' portfolio includes niche generic products, products with formulation improvements, and redesigned products for patient safety and convenience, mostly as drug-device combinations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Bahnhof-Park 4, Baar 6340
Telephone
Telephone
+41 799697055
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.expresspharma.in/extrovis-ag-and-dr-reddys-launch-authorised-generic-fluorouracil-cream-0-5-per-cent-in-us-market/

PRESS RELEASE
21 Aug 2025

https://www.ema.europa.eu/en/documents/overview/sugammadex-adroiq-epar-medicine-overview_en.pdf

EMA
16 Jun 2023

https://www.ema.europa.eu/en/documents/overview/lacosamide-adroiq-epar-medicine-overview_en.pdf

EMA
05 Jun 2023

https://www.marketscreener.com/quote/stock/MEGASOFT-LIMITED-6498580/news/Megasoft-Limited-completed-the-acquisition-of-40-stake-in-Extrovis-AG-42781952/

MARKET SCREENER
19 Jan 2023

https://www.marketscreener.com/quote/stock/MEGASOFT-LIMITED-6498580/news/Megasoft-Limited-agreed-to-acquire-40-stake-in-EXTROVIS-AG-for-16-million-40454341/

MARKETSCREENER
15 May 2022

Services

Upload your portfolio for free, ask us

API Manufacturing

Click here to discover the service providers for API Manufacturing

API & Drug Product Development

Click here to discover the service providers for API & Drug Product Development

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Extrovis AG and get a quotation

Extrovis AG is a supplier offers 8 products (APIs, Excipients or Intermediates).

Find a price of Dapsone bulk with DMF, CEP offered by Extrovis AG

Find a price of Calcium Gluconate bulk with DMF offered by Extrovis AG

Find a price of Eltrombopag bulk with DMF offered by Extrovis AG

Find a price of Potassium Dihydrogen Phosphate bulk with DMF offered by Extrovis AG

Find a price of Potassium Phosphate bulk with DMF offered by Extrovis AG

Find a price of Tolvaptan bulk with DMF offered by Extrovis AG

Find a price of Trabectedin bulk with DMF offered by Extrovis AG

Find a price of Sugammadex Sodium bulk offered by Extrovis AG

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty